| Factor Xa inhibitors--a review of the recent patent literature. | |
| | |
MedLine Citation:
|
PMID: 16037860 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
This review covers the patent literature and related scientific reports in the field of factor Xa inhibitors published between January 1999 and June 2000. During this time, the amount of scientific information as well as the number of newly published patent applications has continuously increased. It is the aim of this review to give an overview of the different structural types of factor Xa inhibitors, to clarify the relationship between newly claimed and previously known inhibitors, and assess the clinical potential of the different factor Xa inhibitors. |
| | |
Authors:
|
U J Ries; H W Priepke |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: IDrugs : the investigational drugs journal Volume: 3 ISSN: 1369-7056 ISO Abbreviation: IDrugs Publication Date: 2000 Dec |
Date Detail:
|
Created Date: 2005-07-22 Completed Date: 2005-09-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883655 Medline TA: IDrugs Country: England |
Other Details:
|
Languages: eng Pagination: 1509-24 Citation Subset: - |
Affiliation:
|
Department of Chemical Research, Boehringer Ingelheim Pharma KG, D-88397, Biberach/RiSS, Germany. uwe.ries@bc.boehringer-ingelheim.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Photodynamic therapy comes of age.
Next Document: Decitabine (SuperGen).